Search clinical trials for: 7.2% NaCl plus 6% hydroxyethyl starch 200/0.5

Total 30 results

Meshalkin Research Institute of Pathology of Circulation

Completed

The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients. (ESHHS)

Coronary Artery Disease | Edema

Russian Federation
Oslo University Hospital

Completed

HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH Patients

Subarachnoid Hemorrhage
Haukeland University Hospital

Withdrawn

"The Effect of Reduced Fluid Load After Cardiac Surgery"

Fluid Overload | Organ Edema | Organ Function
Haukeland University Hospital

Completed

Hypertonic Saline-hetastarch in Cardiac Surgery (HH)

Postoperative Cardiorespiratory Failure

Norway
Fresenius Kabi Japan

Completed

Trial of 6% HES130/0.4

Hemorrhage | Hypovolemia

Japan
London Health Sciences Centre

Terminated

Starch or Saline After Cardiac Surgery (SSACS)

Coronary Artery Bypass Surgery

Canada
Fresenius Kabi

Completed

Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis (CRYSTMAS)

Sepsis

France, Germany
Fresenius Kabi Japan

Completed

Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery

Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage

Japan
Asan Medical Center

Completed

Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy

Pancreaticoduodenectomy

Korea, Republic of
Sifa University

Unknown

Colloid Preload Versus Colloid Coload During Cesarean Deliveries

Hypotension | Anesthesia; Adverse Effect, Spinal and Epidural

Turkey
Yonsei University

Completed

Respirophasic Carotid Artery Peak Velocity Variation as a Predictor of Fluid Responsiveness in Patients With Coronary Disease

Coronary Artery Occlusive Disease

Korea, Republic of
Yonsei University

Completed

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Mitral Valvular Heart Disease
Anders Perner
Rigshospitalet, Denmark; University of Copenhagen; B. Braun Melsungen AG; Copenhagen...

Completed

Scandinavian Starch for Severe Sepsis/Septic Shock Trial (6S)

Septic Shock | Severe Sepsis

Denmark, Norway, Finland, Iceland
Yonsei University

Completed

The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

Coronary Artery Occlusive Disease

Korea, Republic of
Fresenius Kabi
B. Braun Melsungen AG; European Society of Anaesthesiology and Intensive Care

Completed

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery (PHOENICS)

Hypovolaemia Due to Acute Blood Loss

Spain, France, Netherlands, Germany, Poland, Belgium, Czechia, Croatia, Austria, Romania
Fresenius Kabi

Completed

VolulyteTM in Cardiac Surgery

Heart; Dysfunction Postoperative, Cardiac Surgery

Canada
University Hospital Muenster
Fresenius Kabi

Terminated

Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery (KoKris)

Surgery, Colorectal

Germany
Sangart

Completed

Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

Vascular Disease | Critical Lower Limb Ischemia

Sweden
Fresenius Kabi

Terminated

Fluid Resuscitation in Patients Suffering From Burns Injury

Burns

United Kingdom
Oslo University Hospital
BioPhausia

Completed

Hypertonic Saline Dextran in Pediatric Cardiac Surgery

Heart Defects, Congenital | Transposition of Great Vessels | Heart Septal Defects, Ventricular | Endocardial Cushion Defects
Sangart

Completed

Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty

Ischemia | Hypotension

Netherlands, Belgium, Czech Republic, Sweden, Poland, United Kingdom
Sangart

Completed

Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty

Ischemia | Hypotension

Netherlands, Belgium, Sweden, Czech Republic, Poland
Fresenius Kabi

Completed

Voluven® in Paediatric Patients

Cardiac Surgery | Cardiopulmonary Bypass

Austria, Belgium
Vanderbilt University Medical Center
National Institutes of Health (NIH); National Institute of General Medical...

Terminated

Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm

Aneurysmal Subarachnoid Hemorrhage | Cerebral Vasospasm

United States
Assiut University

Completed

Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia

Coagulation Defect; Bleeding

Egypt
Chiesi Farmaceutici S.p.A.

Completed

Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder

Asthmatic

United Kingdom
Medical College of Wisconsin

Completed

Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients

Wounds and Injuries | Rib Fractures

United States
Karolinska Institutet

Terminated

Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture (GDHT)

Femoral Fracture

Sweden
University of Jena

Completed

Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss

Abortion, Habitual

Germany, Austria
University of Michigan Rogel Cancer Center
Rush University Medical Center

Completed

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer

United States

Search clinical trials for: 7.2% NaCl plus 6% hydroxyethyl starch 200/0.5

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations